Holdings of First Trust NYSE Arca Biotechnology Index Fund
First Trust Exchange-Traded Fund · Original filing · Compare with another fund · Report an error
- Net assets
- 2.3B $ including 2.3B $ in equities, 100.0 %
- Positions
- 30 in 5 countries
- Top ten
- 39.9 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Moderna Inc | 2,351,289 | 119.4M $ | 5.26 % |
| 2 | United Therapeutics Corp | 166,849 | 98.9M $ | 4.36 % |
| 3 | Alkermes PLC | 2,719,064 | 96.1M $ | 4.24 % |
| 4 | Gilead Sciences Inc | 665,992 | 92.8M $ | 4.09 % |
| 5 | Axsome Therapeutics Inc | 521,878 | 88.2M $ | 3.89 % |
| 6 | Amgen Inc | 247,283 | 87M $ | 3.83 % |
| 7 | Corcept Therapeutics Inc | 2,150,626 | 86.7M $ | 3.82 % |
| 8 | Krystal Biotech Inc | 308,504 | 79.7M $ | 3.51 % |
| 9 | Biogen Inc | 429,853 | 78.8M $ | 3.47 % |
| 10 | Exelixis Inc | 1,831,270 | 78.5M $ | 3.46 % |
| 11 | Neurocrine Biosciences Inc | 593,926 | 78.2M $ | 3.45 % |
| 12 | Regeneron Pharmaceuticals, Inc. | 101,249 | 78.2M $ | 3.45 % |
| 13 | Vertex Pharmaceuticals Inc | 173,834 | 77.6M $ | 3.42 % |
| 14 | BioMarin Pharmaceutical Inc | 1,368,040 | 77.3M $ | 3.40 % |
| 15 | Argenx SE | 102,325 | 74.7M $ | 3.29 % |
| 16 | Sarepta Therapeutics Inc | 3,384,344 | 73.6M $ | 3.24 % |
| 17 | Halozyme Therapeutics Inc | 1,112,843 | 71.9M $ | 3.17 % |
| 18 | BioNTech SE | 807,711 | 71.8M $ | 3.16 % |
| 19 | Incyte Corp | 754,631 | 71M $ | 3.13 % |
| 20 | BEONE MEDICINES LTD | 238,672 | 70.9M $ | 3.12 % |
| 21 | Illumina Inc | 571,731 | 70.5M $ | 3.10 % |
| 22 | Natera Inc | 344,198 | 68.8M $ | 3.03 % |
| 23 | ACADIA Pharmaceuticals Inc | 3,011,495 | 67M $ | 2.95 % |
| 24 | Alnylam Pharmaceuticals Inc | 202,492 | 67M $ | 2.95 % |
| 25 | Bio-Techne Corp | 1,227,575 | 64.2M $ | 2.83 % |
| 26 | Genmab A/S | 2,354,019 | 63.2M $ | 2.78 % |
| 27 | Veracyte Inc | 1,918,341 | 61.8M $ | 2.72 % |
| 28 | Repligen Corp | 483,433 | 57M $ | 2.51 % |
| 29 | Bruker Corp | 1,480,923 | 53.5M $ | 2.36 % |
| 30 | NeoGenomics Inc | 6,128,278 | 45.5M $ | 2.00 % |
Sector breakdown
- Health care 43.4 %
- Unattributed 56.6 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 86.5 %
- Ireland 4.2 %
- Netherlands 3.3 %
- Germany 3.2 %
- Denmark 2.8 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 26 | 2B $ | 86.53 % |
| 2 | Ireland | 1 | 96.1M $ | 4.24 % |
| 3 | Netherlands | 1 | 74.7M $ | 3.29 % |
| 4 | Germany | 1 | 71.8M $ | 3.16 % |
| 5 | Denmark | 1 | 63.2M $ | 2.78 % |
Cite this page
Titelia. "Holdings of First Trust NYSE Arca Biotechnology Index Fund". https://titelia.com/en/funds/S000012478